Admera Health is designing advanced molecular diagnostics and pharmacogenomics (PGx) solutions to facilitate personalized medicine and non-invasive cancer testing. PGx involves understanding the relationship between a person's genetic makeup and their response to different drugs to develop effective and safe medications tailored to the individual. Admera has built their flagship product, PGxOne Plus, that incorporates next-generation gene sequencing design applications and expert data curation to offer a comprehensive test built to enable smarter and safer medication management. Admera’s portfolio of genetic tests also include OncoGxOne for solid tumor profiling and CardioGxOne for cardiovascular disease conditions.
Claim company profile to post jobs directly on this page and this website.